WAVE Life Sciences (WVE) PT Lowered to $6 at Stifel
Stifel analyst Paul Matteis lowered the price target on WAVE Life Sciences (NASDAQ: WVE) to $6.00 (from $7.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)